ATS International Conference Committee chair and chair-elect, Drs. Debra M. Boyer and Jennifer Taylor-Cousar, will discuss results from the ASPEN study with Drs. James Chalmers and Doreen J. Addrizzo-Harris on Wednesday, Aug. 21st, 1-2 p.m. ET.
On May 28, 2024, Insmed announced positive topline results from the ASPEN Study of Brensocatib in Patients with Bronchiectasis.
Drs. Chalmers and Addrizzo-Harris will present data, answer questions and share additional positive results from this landmark trial.
Please join us for this post ATS 2024 webinar.